BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
PRODID:-//Telerik Inc.//Sitefinity CMS 14.4//EN
BEGIN:VTIMEZONE
TZID:Mountain Standard Time
BEGIN:STANDARD
DTSTART:20251102T020000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYHOUR=2;BYMINUTE=0;BYMONTH=11
TZNAME:Mountain Standard Time
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20250301T020000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYHOUR=2;BYMINUTE=0;BYMONTH=3
TZNAME:Mountain Daylight Time
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:Fellow Presentations\n\nJay Hesselberth\, PhD\nCohort 3\nMethod
 s for understanding functional heterogeneity among single cells\n\nTim McK
 insey\, PhD\nCohort 2\nTargeting a Myofibril Post-translational Modificati
 ons to Treat Heart Failure\n\nFor information on how to join the session\,
  contact Claire McDonald.&nbsp\;
DTEND:20210708T000000Z
DTSTAMP:20260412T095017Z
DTSTART:20210707T220000Z
LOCATION:
SEQUENCE:0
SUMMARY:SPARK Oncology July 2021
UID:RFCALITEM639115842172557381
X-ALT-DESC;FMTTYPE=text/html:<p><strong>Fellow Presentations<br />\n</stron
 g><br />\nJay Hesselberth\, PhD<br />\nCohort 3<br />\nMethods for underst
 anding functional heterogeneity among single cells<br />\n<br />\nTim McKi
 nsey\, PhD<br />\nCohort 2<br />\nTargeting a Myofibril Post-translational
  Modifications to Treat Heart Failure<br />\n<br />\nFor information on ho
 w to join the session\, contact <a href="mailto:claire.mcdonald@cuanschutz
 .edu?subject=SPARK%20Wednesday%20sessions%20">Claire McDonald</a>.&nbsp\;<
 /p>
END:VEVENT
END:VCALENDAR